Complemento alimenticio de uso diario a base de:

  • Fosfatidilserina
  • Vitamina E
  • Vitamina B6-B12
  • Ácido fólico
Om3gafortSCC utiliza ácidos grasos poliinsaturados Omega-3 EPA/DHA de ALTA CONCENTRACIÓN, EFICACIA, PUREZA y SEGURIDAD obtenidos con una tecnología ECOLÓGICA conocida como Supercritical Concentration (SCC).

Omegafort concentración, una combinación ganadora



Dosis diaria: 1 cápsula. CDR referido a dosis diaria.

1 cápsula % CDR*
Ácidos grasos omega-3# 355,52 mg **
DHA (ácido docosahexaenoico) 266,64 mg **
Otros omega-3 88,88 mg **
Otros ingredientes principales  **
Fosfatidilserina 15,0 mg **
Vitamina E 12,0 mg 100%
Vitamina B6 1,4 mg 100%
Ácido fólico 200 µg 100%
Vitamina B12 2,5 µg 100%
*Cantidades Diarias Recomendadas establecidas en la Directiva 2008/100/CE de 28 de octubre de 2008.
**Cantidades Diarias Recomendadas no establecidas.
#Cantidad mínima garantizada de ingrediente activo en mg. Los porcentajes calculados sobre la cantidad mínima en mg pueden variar.


Aceite de pescado (mínimo: 60% de DHA [ácido docosahexaenoico] y de otros omega-3), gelatina, glicerina, fosfatidilserina, vitamina E (acetato de D-alfa-tocoferilo), vitamina B6 (clorhidrato de piridoxina), antioxidantes: extracto rico en tocoferoles, ácido fólico (ácido pteroilmonoglutámico), vitamina B12 (cianocobalamina), colorantes (E 171 y E 131).

Mayor concentración, mayor eficacia

  1. Yurko-Mauro K. Cognitive and cardiovascular benefits of docosahexaenoic acid in aging and cognitive decline. Curr Alzheimer Res. 2010 May 1;7(3):190-6.
  2. Bourre JM. Roles of unsaturated fatty acids (especially omega-3 fatty acids) in the brain at various ages and during ageing. J Nutr Health Aging. 2004;8(3):163-74.
  3. Bourre JM. Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 2 : macronutrients. J Nutr Health Aging. 2006 Sep-Oct;10(5):386-99.
  4. Cherubini A, Andres-Lacueva C, Martin A, Lauretani F, Iorio AD, Bartali B, Corsi A, Bandinelli S, Mattson MP, Ferrucci L. Low plasma N-3 fatty acids and dementia in older persons: the InCHIANTI study. J Gerontol A Biol Sci Med Sci. 2007 Oct;62(10):1120-6.
  5. Robinson JG, Ijioma N, Harris W. Omega-3 fatty acids and cognitive function in women. Womens Health (Lond Engl). 2010 Jan;6(1):119-34.
  6. Dangour AD, Clemens F, Elbourne D, Fasey N, Fletcher AE, Hardy P, Holder GE, Huppert FA, Knight R, Letley L, Richards M, Truesdale A, Vickers M, Uauy R. A randomised controlled trial investigating the effect of n-3 long-chain polyunsaturated fatty acid supplementation on cognitive and retinal function in cognitively healthy older people: the Older People And n-3 Long-chain polyunsaturated fatty acids (OPAL) study protocol [ISRCTN72331636]. Nutr J. 2006 Aug 31;5:20.
  7. Dangour AD, Allen E, Elbourne D, Fletcher A, Richards M, Uauy R. Fish consumption and cognitive function among older people in the UK: baseline data from the OPAL study. J Nutr Health Aging. 2009 Mar;13(3):198-202.
  8. Morris MC, Evans DA, Tangney CC, Bienias JL, Wilson RS. Fish consumption and cognitive decline with age in a large community study. Arch Neurol. 2005 Dec;62(12):1849-53. Epub 2005 Oct 10.
  9. Dangour AD, Uauy R. N-3 long-chain polyunsaturated fatty acids for optimal function during brain development and ageing. Asia Pac J Clin Nutr. 2008;17 Suppl 1:185-8.
  10. Muldoon MF, Ryan CM, Sheu L, Yao JK, Conklin SM, Manuck SB. Serum phospholipid docosahexaenonic acid is associated with cognitive functioning during middle adulthood. J Nutr. 2010 Apr;140(4):848-53. Epub 2010 Feb 24.
  1. Kidd PM. Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids. Altern Med Rev. 2007 Sep;12(3):207-27.
  2. Kingsley M. Effects of phosphatidylserine supplementation on exercising humans. Sports Med. 2006;36(8):657-69.
  3. Ohkubo T, Tanaka Y. Administration of DHA-PS to aged mice was suitable for increasing hippocampal PS and DHA ratio. J Oleo Sci. 2010;59(5):247-53.
  4. Datsenko ZM, Volkov HL, Kryvenko OM, Nechytailo LO, Shovkun SA, Khmel’ TO, Perederii OF. Effect of phospholipids containing omega-3 fatty acids on structural changes of microsomal lipids in cell membranes of functionally different cells. Ukr Biokhim Zh. 2002 Jul-Aug;74(4):44-9.
  1. Malouf M, Grimley EJ, Areosa SA. Folic acid with or without vitamin B12 for cognition and dementia. Cochrane Database Syst Rev. 2003;(4):CD004514.
  2. Bourre JM. Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 1: micronutrients. J Nutr Health Aging. 2006 Sep-Oct;10(5):377-85.